(-)-Epicatechin and its metabolites prevent palmitate-induced NADPH oxidase upregulation, oxidative stress and insulin resistance in HepG2 cells

Archives of Biochemistry and Biophysics

Volumn 646, Issue , 2018, Pages 55-63

  Cremonini, Eleonora ^a   Oteiza, Patricia I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOCYNIN; DRUG METABOLITE; EPICATECHIN; I KAPPA B KINASE; JANUS KINASE 1; JANUS KINASE 2; OXIDOREDUCTASE INHIBITOR; PALMITIC ACID; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; UNCLASSIFIED DRUG; VAS 2870; 3-BENZYL-7-(2-BENZOXAZOLYL)THIO-1,2,3-TRIAZOLO(4,5-D)PYRIMIDINE; ACETOPHENONE DERIVATIVE; BENZOXAZOLE DERIVATIVE; CATECHIN; ENZYME INHIBITOR; NOX3 PROTEIN, HUMAN; NOX4 PROTEIN, HUMAN; PALMITIC ACID DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; LIVER CELL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HEP-G2 CELL LINE; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; UPREGULATION;

ACETOPHENONES; ANIMALS; BENZOXAZOLES; CATECHIN; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; ENZYME INHIBITORS; HEP G2 CELLS; HUMANS; INSULIN RESISTANCE; MALE; MICE, INBRED C57BL; NADPH OXIDASE 4; NADPH OXIDASES; OXIDATIVE STRESS; PALMITATES; SIGNAL TRANSDUCTION; TRIAZOLES; UP-REGULATION;

EID: 85044965469     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2018.03.027     Document Type: Article

References (48)

1. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet (London, England) 387:10026 (2016), 1377–1396.
2. Montonen, J., Knekt, P., Harkanen, T., Jarvinen, R., Heliovaara, M., Aromaa, A., Reunanen, A., Dietary patterns and the incidence of type 2 diabetes. Am. J. Epidemiol. 161:3 (2005), 219–227.
3. Styskal, J., Van Remmen, H., Richardson, A., Salmon, A.B., Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models?. Free Radic. Biol. Med. 52:1 (2012), 46–58.
4. Rains, J.L., Jain, S.K., Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med. 50:5 (2011), 567–575.
5. Henriksen, E.J., Diamond-Stanic, M.K., Marchionne, E.M., Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic. Biol. Med. 51:5 (2011), 993–999.
6. Brandes, R.P., Weissmann, N., Schroder, K., Nox family NADPH oxidases: Molecular mechanisms of activation. Free Radic. Biol. Med. 76 (2014), 208–226.
7. Gao, D., Nong, S., Huang, X., Lu, Y., Zhao, H., Lin, Y., Man, Y., Wang, S., Yang, J., Li, J., The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J. Biol. Chem. 285:39 (2010), 29965–29973.
8. Singh, A., Koduru, B., Carlisle, C., Akhter, H., Liu, R.M., Schroder, K., Brandes, R.P., Ojcius, D.M., NADPH oxidase 4 modulates hepatic responses to lipopolysaccharide mediated by Toll-like receptor-4. Sci. Rep., 7(1), 2017, 14346.
9. Bettaieb, A., Cremonini, E., Kang, H., Kang, J., Haj, F.G., Oteiza, P.I., Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice. Int. J. Biochem. Cell Biol. 81:Pt B (2016), 383–392.
10. Bettaieb, A., Vazquez-Prieto, M.A., Lanzi, C.R., Miatello, R.M., Haj, F.G., Fraga, C.G., Oteiza, P.I., (-)-Epicatechin mitigates high fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radical Biol. Med. 72 (2014), 247–256.
11. Guichard, C., Moreau, R., Pessayre, D., Epperson, T.K., Krause, K.H., NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes?. Biochem. Soc. Trans. 36:Pt 5 (2008), 920–929.
12. Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R.A., Warnholtz, A., Meinertz, T., Griendling, K., Harrison, D.G., Forstermann, U., Munzel, T., Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88:2 (2001), E14–E22.
13. Gorin, Y., Block, K., Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?. Free Radic. Biol. Med. 61 (2013), 130–142.
14. Elnakish, M.T., Hassanain, H.H., Janssen, P.M., Angelos, M.G., Khan, M., Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase. J. Pathol. 231:3 (2013), 290–300.
15. Harnly, J.M., Doherty, R.F., Beecher, G.R., Holden, J.M., Haytowitz, D.B., Bhagwat, S., Gebhardt, S., Flavonoid content of U.S. fruits, vegetables, and nuts. J. Agric. Food Chem. 54:26 (2006), 9966–9977.
16. Ramirez-Sanchez, I., Taub, P.R., Ciaraldi, T.P., Nogueira, L., Coe, T., Perkins, G., Hogan, M., Maisel, A.S., Henry, R.R., Ceballos, G., Villarreal, F., (-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients. Int. J. Cardiol. 168:4 (2013), 3982–3990.
17. Grassi, D., Desideri, G., Necozione, S., Lippi, C., Casale, R., Properzi, G., Blumberg, J.B., Ferri, C., Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J. Nutr. 138:9 (2008), 1671–1676.
18. Grassi, D., Lippi, C., Necozione, S., Desideri, G., Ferri, C., Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am. J. Clin. Nutr. 81:3 (2005), 611–614.
19. Curtis, P.J., Sampson, M., Potter, J., Dhatariya, K., Kroon, P.A., Cassidy, A., Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial. Diabetes Care 35:2 (2012), 226–232.
20. Davison, K., Coates, A.M., Buckley, J.D., Howe, P.R., Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int. J. Obes. 32:8 (2008), 1289–1296.
21. Montagut, G., Blade, C., Blay, M., Fernandez-Larrea, J., Pujadas, G., Salvado, M.J., Arola, L., Pinent, M., Ardevol, A., Effects of a grapeseed procyanidin extract (GSPE) on insulin resistance. J. Nutr. Biochem. 21:10 (2010), 961–967.
22. Shrime, M.G., Bauer, S.R., McDonald, A.C., Chowdhury, N.H., Coltart, C.E., Ding, E.L., Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J. Nutr. 141:11 (2011), 1982–1988.
23. Cremonini, E., Bettaieb, A., Haj, F.G., Fraga, C.G., Oteiza, P.I., (-)-Epicatechin improves insulin sensitivity in high fat diet-fed mice. Arch. Biochem. Biophys. 599 (2016), 13–21.
24. Cremonini, E., Wang, Z., Bettaieb, A., Adamo, A.M., Daveri, E., Mills, D.A., Kalanetra, K.M., Haj, F.G., Karakas, S., Oteiza, P.I., (-)-Epicatechin protects the intestinal barrier from high fat diet-induced permeabilization: implications for steatosis and insulin resistance. Redox Biol 14 (2018), 588–599.
25. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C.Z., Uysal, K.T., Maeda, K., Karin, M., Hotamisligil, G.S., A central role for JNK in obesity and insulin resistance. Nature 420:6913 (2002), 333–336.
26. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.W., Karin, M., Shoelson, S.E., Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:5535 (2001), 1673–1677.
27. Engin, A., Human protein kinases and obesity. Engin, A.B., Engin, A., (eds.) Obesity and Lipotoxicity, 2017, Springer International Publishing, Cham, 111–134.
28. Borges, G., Ottaviani, J.I., van der Hooft, J.J.J., Schroeter, H., Crozier, A., Absorption, metabolism, distribution and excretion of (-)-epicatechin: a review of recent findings. Mol. Aspect. Med. S0098–2997:17 (2017), 30143–30147.
29. Ottaviani, J.I., Momma, T.Y., Kuhnle, G.K., Keen, C.L., Schroeter, H., Structurally related (-)-epicatechin metabolites in humans: assessment using de novo chemically synthesized authentic standards. Free Radic. Biol. Med. 50:2 (2011), 237–244.
30. Actis-Goretta, L., Leveques, A., Giuffrida, F., Romanov-Michailidis, F., Viton, F., Barron, D., Duenas-Paton, M., Gonzalez-Manzano, S., Santos-Buelga, C., Williamson, G., Dionisi, F., Elucidation of (-)-epicatechin metabolites after ingestion of chocolate by healthy humans. Free Radic. Biol. Med. 53:4 (2012), 787–795.
31. Ertunc, M.E., Hotamisligil, G.S., Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment. J. Lipid Res. 57:12 (2016), 2099–2114.
32. Fraga, C.G., Oteiza, P.I., Galleano, M., Plant bioactives and redox signaling: (-)-Epicatechin as a paradigm. Mol. Aspect. Med. S0098–2997:18 (2018), 30002–30005.
33. Vazquez-Prieto, M.A., Bettaieb, A., Haj, F.G., Fraga, C.G., Oteiza, P.I., (-)-Epicatechin prevents TNFalpha-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 527:2 (2012), 113–118.
34. Aimo, L., Mackenzie, G.G., Keenan, A.H., Oteiza, P.I., Gestational zinc deficiency affects the regulation of transcription factors AP-1, NF-kappaB and NFAT in fetal brain. J. Nutr. Biochem. 21:11 (2010), 1069–1075.
35. Levine, R.L., Wehr, N., Williams, J.A., Stadtman, E.R., Shacter, E., Determination of carbonyl groups in oxidized proteins. Meth. Mol. Biol. 99 (2000), 15–24.
36. Inoguchi, T., Li, P., Umeda, F., Yu, H.Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., Sano, H., Utsumi, H., Nawata, H., High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C–dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:11 (2000), 1939–1945.
37. Graciano, M.F., Santos, L.R., Curi, R., Carpinelli, A.R., NAD(P)H oxidase participates in the palmitate-induced superoxide production and insulin secretion by rat pancreatic islets. J. Cell. Physiol. 226:4 (2011), 1110–1117.
38. Fedorova, M., Bollineni, R.C., Hoffmann, R., Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies. Mass Spectrom. Rev. 33:2 (2014), 79–97.
39. Brown, D.I., Griendling, K.K., Nox proteins in signal transduction. Free Radic. Biol. Med. 47:9 (2009), 1239–1253.
40. Rastogi, R., Geng, X., Li, F., Ding, Y., NOX activation by subunit interaction and underlying mechanisms in disease. Front. Cell. Neurosci., 10, 2016, 301.
41. Hansen, S.S., Aasum, E., Hafstad, A.D., The role of NADPH oxidases in diabetic cardiomyopathy. Biochim. Biophys. Acta S0925–4439:17 (2017), 30257–30260.
42. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., Shimomura, I., Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114:12 (2004), 1752–1761.
43. Steffen, Y., Gruber, C., Schewe, T., Sies, H., Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys. 469:2 (2008), 209–219.
44. Manea, A., Tanase, L.I., Raicu, M., Simionescu, M., Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 396:4 (2010), 901–907.
45. Kim, S.Y., Jeong, J.M., Kim, S.J., Seo, W., Kim, M.H., Choi, W.M., Yoo, W., Lee, J.H., Shim, Y.R., Yi, H.S., Lee, Y.S., Eun, H.S., Lee, B.S., Chun, K., Kang, S.J., Kim, S.C., Gao, B., Kunos, G., Kim, H.M., Jeong, W.I., Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex. Nat. Commun., 8(1), 2017, 2247.
46. Ly, L.D., Xu, S., Choi, S.K., Ha, C.M., Thoudam, T., Cha, S.K., Wiederkehr, A., Wollheim, C.B., Lee, I.K., Park, K.S., Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes. Exp. Mol. Med., 49(2), 2017, e291.
47. Grimsrud, P.A., Picklo, M.J. Sr., Griffin, T.J., Bernlohr, D.A., Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol. Cell. Proteomics 6:4 (2007), 624–637.
48. Galleano, M., Verstraeten, S.V., Oteiza, P.I., Fraga, C.G., Antioxidant actions of flavonoids: thermodynamic and kinetic analysis. Arch. Biochem. Biophys. 501:1 (2010), 23–30.